Perthera

Cancer is relentless—we’re even more so. At Perthera, we are scientists, technologists, and healthcare leaders on a mission to extend the lives of cancer patients. Our AI-driven Perthera Report® empowers oncologists with ranked treatment options, backed by real-world outcomes, and has been clinically proven to improve survival 2.4X. Trusted by 1,500+ oncologists at 600+ cancer centers nationwide, our patented technology personalizes therapy decisions and accelerates breakthroughs for biopharma, providing critical data and insights to speed oncology innovations to market. Now, we’re transforming pancreatic cancer care with Perthera Report® Pancreatic—the world’s first frontline chemotherapy predictor and a comprehensive precision oncology solution designed to optimize treatment at every stage.